Page last updated: 2024-08-26

5-formyl-2'-deoxyuridine and Peritoneal Carcinomatosis

5-formyl-2'-deoxyuridine has been researched along with Peritoneal Carcinomatosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giuashvili, S; Königsrainer, A; Reymond, M; Sautkin, I; Schott, TC; Struller, F; Weinreich, J1

Other Studies

1 other study(ies) available for 5-formyl-2'-deoxyuridine and Peritoneal Carcinomatosis

ArticleYear
Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro.
    Investigational new drugs, 2019, Volume: 37, Issue:3

    Topics: Adult; Aged; Apoptosis; Cell Proliferation; Cisplatin; Colonic Neoplasms; Cytidine; Cytostatic Agents; Deoxyuridine; Doxorubicin; Female; Humans; Hyperthermia, Induced; In Vitro Techniques; Middle Aged; Ovarian Neoplasms; Oxaliplatin; Peritoneal Neoplasms; Stomach Neoplasms; Tumor Cells, Cultured

2019